[Federal Register Volume 63, Number 64 (Friday, April 3, 1998)]
[Notices]
[Page 16564]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-8813]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
National Cancer Institute Special Emphasis Panel (SEP) meeting:
Name of SEP: Study to Assess Raloxifene for Preventing Breast
Cancer.
Date: April 22, 1998.
Time: 9:00 a.m. to Adjournment.
Place: The St. James Hotel, 950 24th Street, NW., Washington, DC
20037.
Contact Person: Ray Bramhall, Ph.D., Scientific Review
Administrator, National Cancer Institute, NIH, Executive Plaza
North, Room 636B, 6130 Executive Boulevard, MSC 7405, Bethesda, MD
20892-7405, Telephone: 301/496-3428.
Purpose/Agenda: To review, discuss and evaluate grant
applications.
The meeting will be closed in accordance with the provisions set
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.
Applications and the discussions could reveal confidential trade
secrets or commercial property such as patentable material and
personal information concerning individuals associated with the
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Program Number: 93.393,
Cancer Cause and Prevention Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396,
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398,
Cancer Research Manpower; 93.399, Cancer Control)
Dated: March 24, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-8813 Filed 4-2-98; 8:45 am]
BILLING CODE 4140-01-M
